{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:29:27Z","timestamp":1674865767041},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of the present study was to assess whether the efficacy of bisphosphonate treatment is influenced by PTH levels measured in newly diagnosed osteoporotic patients and to identify the threshold value, beyond which PTH level negatively influences therapeutic efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred and thirty-eight osteoporotic patients were enrolled into the study. All subjects underwent laboratory screening, bone densitometry with DEXA, and x-ray imaging. The changes in bone density were evaluated after a mean follow-up period of 13.37\u2009\u00b1\u20091.29\u2009months. Correlation analysis was performed on the clinical data of patients, the percentage changes of BMD values, and the PTH levels measured at the beginning of study, using SPSS software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean age of the subjects was 64.82\u2009\u00b1\u200910.51\u2009years, and the female-to-male ratio was 116\/22. Baseline BMD value measured with AP DEXA scanning was 0.854\u2009\u00b1\u20090.108\u2009g\/cm<jats:sup>2<\/jats:sup> in the L<jats:sub>1-4<\/jats:sub> vertebrae and 0.768\u2009\u00b1\u20090.115\u2009g\/cm<jats:sup>2<\/jats:sup> in the left femoral neck. By the end of the follow-up period, these values changed to 0.890\u2009\u00b1\u20090.111\u2009g\/cm<jats:sup>2<\/jats:sup> and 0.773\u2009\u00b1\u20090.111\u2009g\/cm<jats:sup>2<\/jats:sup>, respectively. We found a statistically significant, negative correlation between PTH levels and the percentage changes of lumbar BMD values measured at the end of the follow-up (correlation coefficient R<jats:sup>2<\/jats:sup>\u2009=\u20090.121, p\u2009&lt;\u20090.0001). The analysis of frequency histograms suggested that negative effects on bone might be expected above a PTH level of 60\u2009pg\/mL (7.3 pmol\/L).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings imply that a baseline PTH level over 60\u2009ng\/mL can reduce the efficacy of bisphosphonate treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-13-244","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T21:14:16Z","timestamp":1355174056000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Gy\u00f6ngyv\u00e9r","family":"Kincse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Sur\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Ga\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"issue":"3","key":"1541_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF01622286","volume":"7","author":"M Lunt","year":"1997","unstructured":"Lunt M, Felsenberg D, Adams J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch JA, Johnell O, Khaw KT, Masaryk P, Pols H, Poor G, Reid D, Scheidt-Nave C, Weber K, Silman AJ, Reeve J: Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis Osteoporos Int. 1997, 7 (3): 175-189.","journal-title":"European Vertebral Osteoporosis Osteoporos Int"},{"issue":"5","key":"1541_CR2","first-page":"429","volume":"77","author":"G Po\u00f3r","year":"1999","unstructured":"Po\u00f3r G: Osteoporosis care in hungary. Bull World Health Organ. 1999, 77 (5): 429-430.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1541_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/mol.56.1.131","volume":"56","author":"HL Benford","year":"1999","unstructured":"Benford HL, Frith JC, Auriola S, M\u00f6nkk\u00f6nen J, Rogers MJ: Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol. 1999, 56 (1): 131-140.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1541_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000071707","volume":"49","author":"TJ Allain","year":"2003","unstructured":"Allain TJ, Dhesi J: Hypovitaminosis D in older adults. Gerontology. 2003, 49 (5): 273-278. 10.1159\/000071707.","journal-title":"Gerontology"},{"issue":"4","key":"1541_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P, Vitamin D: Deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001, 22 (4): 477-501. 10.1210\/er.22.4.477.","journal-title":"Endocr Rev"},{"issue":"3","key":"1541_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00223-010-9454-0","volume":"88","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Brot C, Mosekilde L: Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study. Calcif Tissue Int. 2011, 88 (3): 238-425. 10.1007\/s00223-010-9454-0.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1541_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s001980200012","volume":"13","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Begerow B, Minne HW: Vitamin D and muscle function. Osteoporos Int. 2002, 13 (3): 187-194. 10.1007\/s001980200012.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1541_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/gerona\/62.4.440","volume":"62","author":"DK Houston","year":"2007","unstructured":"Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B, Johnson MA, Schwartz GG, Kritchevsky SB: Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2007, 62 (4): 440-446. 10.1093\/gerona\/62.4.440.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1541_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/endo-125-2-935","volume":"125","author":"R Kremer","year":"1989","unstructured":"Kremer R, Bolivar I, Goltzman D, Hendy GN: Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology. 1989, 125 (2): 935-941. 10.1210\/endo-125-2-935.","journal-title":"Endocrinology"},{"issue":"12","key":"1541_CR10","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00198-005-1910-8","volume":"16","author":"DG von M\u00fchlen","year":"2005","unstructured":"von M\u00fchlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E: Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the rancho Bernardo study. Osteoporos Int. 2005, 16 (12): 1721-1726. 10.1007\/s00198-005-1910-8.","journal-title":"Osteoporos Int"},{"issue":"18","key":"1541_CR11","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1001\/jama.294.18.2336","volume":"294","author":"L Steingrimsdottir","year":"2005","unstructured":"Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G: Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005, 294 (18): 2336-2341. 10.1001\/jama.294.18.2336.","journal-title":"JAMA"},{"issue":"5","key":"1541_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s001980050030","volume":"7","author":"MC Chapuy","year":"1997","unstructured":"Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997, 7 (5): 439-443. 10.1007\/s001980050030.","journal-title":"Osteoporos Int"},{"issue":"6","key":"1541_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00198-003-1566-1","volume":"15","author":"HP Bhattoa","year":"2004","unstructured":"Bhattoa HP, Bettembuk P, Ganacharya S, Balogh A: Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int. 2004, 15 (6): 447-451.","journal-title":"Osteoporos Int"},{"issue":"3","key":"1541_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clinthera.2008.03.008","volume":"30","author":"AI Sebba","year":"2008","unstructured":"Sebba AI: Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther. 2008, 30 (3): 443-452. 10.1016\/j.clinthera.2008.03.008.","journal-title":"Clin Ther"},{"issue":"5","key":"1541_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1532-5415.2007.01161.x","volume":"55","author":"A Barone","year":"2007","unstructured":"Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G: Secondary hyperparathyroidism Due to hypovitaminosis D affects bone mineral density response to Alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc. 2007, 55 (5): 752-757. 10.1111\/j.1532-5415.2007.01161.x.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1541_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00296-009-0892-9","volume":"30","author":"J Ga\u00e1l","year":"2009","unstructured":"Ga\u00e1l J, Bender T, Varga J, Horv\u00e1th I, Kiss J, Somogyi P, Sur\u00e1nyi P: Overcoming resistance to bisphosphonates through the administration of alfacalcidol: results of a one-year, open follow-up study. Rheumatol Int. 2009, 30 (1): 25-31. 10.1007\/s00296-009-0892-9.","journal-title":"Rheumatol Int"},{"issue":"11","key":"1541_CR17","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1210\/jc.85.11.4125","volume":"85","author":"SS Harris","year":"2000","unstructured":"Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B: Vitamine D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000, 85 (11): 4125-4130. 10.1210\/jc.85.11.4125.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1541_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1185\/030079907X187964","volume":"23","author":"H Resch","year":"2007","unstructured":"Resch H, Walliser J, Phillips S, Wehren LE, Sen SS: Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective. Curr Med Res Opin. 2007, 23 (6): 1227-1237. 10.1185\/030079907X187964.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"1541_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3109\/13697130903452804","volume":"13","author":"C Castelo-Branco","year":"2010","unstructured":"Castelo-Branco C, Cort\u00e9s X, Ferrer M, UNICAD study investigators: Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric. 2010, 13 (6): 578-584. 10.3109\/13697130903452804.","journal-title":"Climacteric"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1185\/030079905X59148","volume":"21","author":"SJ Gallacher","year":"2005","unstructured":"Gallacher SJ, McQuillian C, Harkness M, Finlay F, Gallagher AP, Dixon T: Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin. 2005, 21: 1355-1361. 10.1185\/030079905X59148.","journal-title":"Curr Med Res Opin"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s001980070074","volume":"11","author":"RP Heaney","year":"2000","unstructured":"Heaney RP: Vitamin D: how much do we need, and how much is too much?. Osteoporos Int. 2000, 11: 553-555. 10.1007\/s001980070074.","journal-title":"Osteoporos Int"},{"issue":"8","key":"1541_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2474-8-3","volume":"10","author":"A Deane","year":"2007","unstructured":"Deane A, Constancio L, Fogelman I, Hampson G: The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord. 2007, 10 (8): 3-10.1186\/1471-2474-8-3.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"1541_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00198-008-0650-y","volume":"20","author":"S Adami","year":"2009","unstructured":"Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M: Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporosis Int. 2009, 20 (2): 239-244. 10.1007\/s00198-008-0650-y.","journal-title":"Osteoporosis Int"},{"issue":"4","key":"1541_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bone.2009.06.012","volume":"45","author":"C von Restorff","year":"2009","unstructured":"von Restorff C, Bischoff-Ferrari HA, Theiler R: High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone. 2009, 45 (4): 747-749. 10.1016\/j.bone.2009.06.012.","journal-title":"Bone"},{"issue":"4","key":"1541_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1530\/EJE-09-0932","volume":"162","author":"L van Groningen","year":"2010","unstructured":"van Groningen L, Opdenoordt S, van Sorge A, Telting D, Giesen A, de Boer H: Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol. 2010, 162 (4): 805-811. 10.1530\/EJE-09-0932.","journal-title":"Eur J Endocrinol"},{"issue":"18","key":"1541_CR26","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010, 303 (18): 1815-1822. 10.1001\/jama.2010.594.","journal-title":"JAMA"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-13-244\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:00:02Z","timestamp":1630530002000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-13-244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-13-244","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"8 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"244"}}